BioCardia (BCDA) announces the appointment of Farhan Shahab as Vice President of Quality. Shahab joins BioCardia from Welldoc, where he served as Vice President of Quality and Regulatory
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BCDA:
- BioCardia’s Earnings Call: Progress Amid Financial Challenges
- BioCardia’s Strategic Advancements and Financial Stability Drive Buy Rating
- BioCardia’s Q3 2025: Clinical Progress and Financial Stability
- BioCardia first patient enrolled at Henry Ford Health for Phase 3 CardiAMP
- BioCardia Enrolls First Patient in Phase 3 Trial